Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
27.66
-0.11 (-0.40%)
At close: Sep 11, 2026, 4:00 PM EDT
27.89
+0.23 (0.83%)
After-hours: Sep 11, 2026, 4:10 PM EDT

Alamar Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-49.66-29.82-47.07
Depreciation & Amortization
3.262.762.29
Other Amortization
1.341.290.98
Loss (Gain) From Sale of Investments
-0.04-0.12-1.89
Stock-Based Compensation
6.322.870.87
Other Operating Activities
13.451.981.59
Change in Accounts Receivable
-10.88-5.5-5.1
Change in Inventory
-21.35-23.78-8.75
Change in Accounts Payable
8.32-0.572.92
Change in Other Net Operating Assets
-11.22-2.72-1.06
Operating Cash Flow
-60.33-53.61-55.21
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-8.31-5.37-2.95
Sale (Purchase) of Intangibles
-0.51-1.01-0.44
Investment in Securities
-101.5552.56-50.55
Investing Cash Flow
-110.3646.18-53.93

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Long-Term Debt Issued
-10-
Long-Term Debt Repaid
---15
Net Debt Issued (Repaid)
60.3510-15
Issuance of Common Stock
208.661.490.94
Other Financing Activities
-0.98-0.66-
Financing Cash Flow
268.0310.84113.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
-0.69-0.17-0
Net Cash Flow
96.663.234.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-68.64-58.98-58.16
Free Cash Flow Growth
---
Free Cash Flow Margin
-68.35%-79.48%-231.33%
Free Cash Flow Per Share
-2.90-5.11-4.89
Levered Free Cash Flow
--49.7-
Unlevered Free Cash Flow
--49.65-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Interest Paid
0.430.132.05
Change in Working Capital
-35.14-32.57-11.99
SEC Filings: 10-K · 10-Q